Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate Cancer
Maximilian Peter Brandt(Johannes Gutenberg University Mainz), Martin Puhr(Innsbruck Medical University)
Cited by 3
Related Papers
SOCS-3 antagonises the proliferative and migratory effects of fibroblast growth factor-2 in prostate cancer by inhibition of p44/p42 MAPK signalling
|Endocrine Related Cancer|2010|41
Impact of socioeconomic factors on the incidence of urothelial cell carcinoma in Germany.
|Journal of Clinical Oncology|2015|0